In - Vitro ADME Services Industry Research Report 2023
Highlights
The global In - Vitro ADME Services market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for In - Vitro ADME Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for In - Vitro ADME Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of In - Vitro ADME Services include Charles River, Labcorp, Envigo, Curia, Evotec, Bioduro-Sundia, Lonza, WuXi AppTec and IQVIA, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for In - Vitro ADME Services in Biopharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Small Molecules, which accounted for % of the global market of In - Vitro ADME Services in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In - Vitro ADME Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In - Vitro ADME Services.
The In - Vitro ADME Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In - Vitro ADME Services market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In - Vitro ADME Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by In - Vitro ADME Services type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the In - Vitro ADME Services are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
In - Vitro ADME Services segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the In - Vitro ADME Services market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the In - Vitro ADME Services market.
In - Vitro ADME Services Segment by End User
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the In - Vitro ADME Services market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In - Vitro ADME Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of In - Vitro ADME Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the In - Vitro ADME Services industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In - Vitro ADME Services.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In - Vitro ADME Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
The global In - Vitro ADME Services market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for In - Vitro ADME Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for In - Vitro ADME Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of In - Vitro ADME Services include Charles River, Labcorp, Envigo, Curia, Evotec, Bioduro-Sundia, Lonza, WuXi AppTec and IQVIA, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for In - Vitro ADME Services in Biopharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Small Molecules, which accounted for % of the global market of In - Vitro ADME Services in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for In - Vitro ADME Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In - Vitro ADME Services.
The In - Vitro ADME Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global In - Vitro ADME Services market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In - Vitro ADME Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Charles River
- Labcorp
- Envigo
- Curia
- Evotec
- Bioduro-Sundia
- Lonza
- WuXi AppTec
- IQVIA
- Tecan Group
- Pharmaron
- Shanghai Medicilon
- ChemPartner
- Joinn Laboratories
- RTI International
- Eurofins Scientific
- Aragen Life Sciences
- Sai Life Sciences
Global markets are presented by In - Vitro ADME Services type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the In - Vitro ADME Services are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
In - Vitro ADME Services segment by Type
- Small Molecules
- Biologics
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the In - Vitro ADME Services market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the In - Vitro ADME Services market.
In - Vitro ADME Services Segment by End User
- Biopharmaceutical Companies
- Government and Academic Institutes
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the In - Vitro ADME Services market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In - Vitro ADME Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of In - Vitro ADME Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the In - Vitro ADME Services industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In - Vitro ADME Services.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In - Vitro ADME Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 In - Vitro ADME Services by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Small Molecules
1.2.3 Biologics
2.3 In - Vitro ADME Services by End User
2.3.1 Market Value Comparison by End User (2018 VS 2022 VS 2029)
2.3.2 Biopharmaceutical Companies
2.3.3 Government and Academic Institutes
2.3.4 Others
2.4 Assumptions and Limitations
3 IN - VITRO ADME SERVICES BREAKDOWN DATA BY TYPE
3.1 Global In - Vitro ADME Services Historic Market Size by Type (2018-2023)
3.2 Global In - Vitro ADME Services Forecasted Market Size by Type (2023-2028)
4 IN - VITRO ADME SERVICES BREAKDOWN DATA BY END USER
4.1 Global In - Vitro ADME Services Historic Market Size by End User (2018-2023)
4.2 Global In - Vitro ADME Services Forecasted Market Size by End User (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global In - Vitro ADME Services Market Perspective (2018-2029)
5.2 Global In - Vitro ADME Services Growth Trends by Region
5.2.1 Global In - Vitro ADME Services Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 In - Vitro ADME Services Historic Market Size by Region (2018-2023)
5.2.3 In - Vitro ADME Services Forecasted Market Size by Region (2024-2029)
5.3 In - Vitro ADME Services Market Dynamics
5.3.1 In - Vitro ADME Services Industry Trends
5.3.2 In - Vitro ADME Services Market Drivers
5.3.3 In - Vitro ADME Services Market Challenges
5.3.4 In - Vitro ADME Services Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top In - Vitro ADME Services Players by Revenue
6.1.1 Global Top In - Vitro ADME Services Players by Revenue (2018-2023)
6.1.2 Global In - Vitro ADME Services Revenue Market Share by Players (2018-2023)
6.2 Global In - Vitro ADME Services Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of In - Vitro ADME Services Head office and Area Served
6.4 Global In - Vitro ADME Services Players, Product Type & Application
6.5 Global In - Vitro ADME Services Players, Date of Enter into This Industry
6.6 Global In - Vitro ADME Services Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America In - Vitro ADME Services Market Size (2018-2029)
7.2 North America In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America In - Vitro ADME Services Market Size by Country (2018-2023)
7.4 North America In - Vitro ADME Services Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe In - Vitro ADME Services Market Size (2018-2029)
8.2 Europe In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe In - Vitro ADME Services Market Size by Country (2018-2023)
8.4 Europe In - Vitro ADME Services Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific In - Vitro ADME Services Market Size (2018-2029)
9.2 Asia-Pacific In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific In - Vitro ADME Services Market Size by Country (2018-2023)
9.4 Asia-Pacific In - Vitro ADME Services Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America In - Vitro ADME Services Market Size (2018-2029)
10.2 Latin America In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America In - Vitro ADME Services Market Size by Country (2018-2023)
10.4 Latin America In - Vitro ADME Services Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa In - Vitro ADME Services Market Size (2018-2029)
11.2 Middle East & Africa In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa In - Vitro ADME Services Market Size by Country (2018-2023)
11.4 Middle East & Africa In - Vitro ADME Services Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River In - Vitro ADME Services Introduction
11.1.4 Charles River Revenue in In - Vitro ADME Services Business (2017-2022)
11.1.5 Charles River Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Detail
11.2.2 Labcorp Business Overview
11.2.3 Labcorp In - Vitro ADME Services Introduction
11.2.4 Labcorp Revenue in In - Vitro ADME Services Business (2017-2022)
11.2.5 Labcorp Recent Development
11.3 Envigo
11.3.1 Envigo Company Detail
11.3.2 Envigo Business Overview
11.3.3 Envigo In - Vitro ADME Services Introduction
11.3.4 Envigo Revenue in In - Vitro ADME Services Business (2017-2022)
11.3.5 Envigo Recent Development
11.4 Curia
11.4.1 Curia Company Detail
11.4.2 Curia Business Overview
11.4.3 Curia In - Vitro ADME Services Introduction
11.4.4 Curia Revenue in In - Vitro ADME Services Business (2017-2022)
11.4.5 Curia Recent Development
11.5 Evotec
11.5.1 Evotec Company Detail
11.5.2 Evotec Business Overview
11.5.3 Evotec In - Vitro ADME Services Introduction
11.5.4 Evotec Revenue in In - Vitro ADME Services Business (2017-2022)
11.5.5 Evotec Recent Development
11.6 Bioduro-Sundia
11.6.1 Bioduro-Sundia Company Detail
11.6.2 Bioduro-Sundia Business Overview
11.6.3 Bioduro-Sundia In - Vitro ADME Services Introduction
11.6.4 Bioduro-Sundia Revenue in In - Vitro ADME Services Business (2017-2022)
11.6.5 Bioduro-Sundia Recent Development
11.7 Lonza
11.7.1 Lonza Company Detail
11.7.2 Lonza Business Overview
11.7.3 Lonza In - Vitro ADME Services Introduction
11.7.4 Lonza Revenue in In - Vitro ADME Services Business (2017-2022)
11.7.5 Lonza Recent Development
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Detail
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec In - Vitro ADME Services Introduction
11.8.4 WuXi AppTec Revenue in In - Vitro ADME Services Business (2017-2022)
11.8.5 WuXi AppTec Recent Development
11.9 IQVIA
11.9.1 IQVIA Company Detail
11.9.2 IQVIA Business Overview
11.9.3 IQVIA In - Vitro ADME Services Introduction
11.9.4 IQVIA Revenue in In - Vitro ADME Services Business (2017-2022)
11.9.5 IQVIA Recent Development
11.10 Tecan Group
11.10.1 Tecan Group Company Detail
11.10.2 Tecan Group Business Overview
11.10.3 Tecan Group In - Vitro ADME Services Introduction
11.10.4 Tecan Group Revenue in In - Vitro ADME Services Business (2017-2022)
11.10.5 Tecan Group Recent Development
11.11 Pharmaron
11.11.1 Pharmaron Company Detail
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron In - Vitro ADME Services Introduction
11.11.4 Pharmaron Revenue in In - Vitro ADME Services Business (2017-2022)
11.11.5 Pharmaron Recent Development
11.12 Shanghai Medicilon
11.12.1 Shanghai Medicilon Company Detail
11.12.2 Shanghai Medicilon Business Overview
11.12.3 Shanghai Medicilon In - Vitro ADME Services Introduction
11.12.4 Shanghai Medicilon Revenue in In - Vitro ADME Services Business (2017-2022)
11.12.5 Shanghai Medicilon Recent Development
11.13 ChemPartner
11.13.1 ChemPartner Company Detail
11.13.2 ChemPartner Business Overview
11.13.3 ChemPartner In - Vitro ADME Services Introduction
11.13.4 ChemPartner Revenue in In - Vitro ADME Services Business (2017-2022)
11.13.5 ChemPartner Recent Development
11.14 Joinn Laboratories
11.14.1 Joinn Laboratories Company Detail
11.14.2 Joinn Laboratories Business Overview
11.14.3 Joinn Laboratories In - Vitro ADME Services Introduction
11.14.4 Joinn Laboratories Revenue in In - Vitro ADME Services Business (2017-2022)
11.14.5 Joinn Laboratories Recent Development
11.15 RTI International
11.15.1 RTI International Company Detail
11.15.2 RTI International Business Overview
11.15.3 RTI International In - Vitro ADME Services Introduction
11.15.4 RTI International Revenue in In - Vitro ADME Services Business (2017-2022)
11.15.5 RTI International Recent Development
11.16 Eurofins Scientific
11.16.1 Eurofins Scientific Company Detail
11.16.2 Eurofins Scientific Business Overview
11.16.3 Eurofins Scientific In - Vitro ADME Services Introduction
11.16.4 Eurofins Scientific Revenue in In - Vitro ADME Services Business (2017-2022)
11.16.5 Eurofins Scientific Recent Development
11.17 Aragen Life Sciences
11.17.1 Aragen Life Sciences Company Detail
11.17.2 Aragen Life Sciences Business Overview
11.17.3 Aragen Life Sciences In - Vitro ADME Services Introduction
11.17.4 Aragen Life Sciences Revenue in In - Vitro ADME Services Business (2017-2022)
11.17.5 Aragen Life Sciences Recent Development
11.18 Sai Life Sciences
11.18.1 Sai Life Sciences Company Detail
11.18.2 Sai Life Sciences Business Overview
11.18.3 Sai Life Sciences In - Vitro ADME Services Introduction
11.18.4 Sai Life Sciences Revenue in In - Vitro ADME Services Business (2017-2022)
11.18.5 Sai Life Sciences Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 In - Vitro ADME Services by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Small Molecules
1.2.3 Biologics
2.3 In - Vitro ADME Services by End User
2.3.1 Market Value Comparison by End User (2018 VS 2022 VS 2029)
2.3.2 Biopharmaceutical Companies
2.3.3 Government and Academic Institutes
2.3.4 Others
2.4 Assumptions and Limitations
3 IN - VITRO ADME SERVICES BREAKDOWN DATA BY TYPE
3.1 Global In - Vitro ADME Services Historic Market Size by Type (2018-2023)
3.2 Global In - Vitro ADME Services Forecasted Market Size by Type (2023-2028)
4 IN - VITRO ADME SERVICES BREAKDOWN DATA BY END USER
4.1 Global In - Vitro ADME Services Historic Market Size by End User (2018-2023)
4.2 Global In - Vitro ADME Services Forecasted Market Size by End User (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global In - Vitro ADME Services Market Perspective (2018-2029)
5.2 Global In - Vitro ADME Services Growth Trends by Region
5.2.1 Global In - Vitro ADME Services Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 In - Vitro ADME Services Historic Market Size by Region (2018-2023)
5.2.3 In - Vitro ADME Services Forecasted Market Size by Region (2024-2029)
5.3 In - Vitro ADME Services Market Dynamics
5.3.1 In - Vitro ADME Services Industry Trends
5.3.2 In - Vitro ADME Services Market Drivers
5.3.3 In - Vitro ADME Services Market Challenges
5.3.4 In - Vitro ADME Services Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top In - Vitro ADME Services Players by Revenue
6.1.1 Global Top In - Vitro ADME Services Players by Revenue (2018-2023)
6.1.2 Global In - Vitro ADME Services Revenue Market Share by Players (2018-2023)
6.2 Global In - Vitro ADME Services Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of In - Vitro ADME Services Head office and Area Served
6.4 Global In - Vitro ADME Services Players, Product Type & Application
6.5 Global In - Vitro ADME Services Players, Date of Enter into This Industry
6.6 Global In - Vitro ADME Services Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America In - Vitro ADME Services Market Size (2018-2029)
7.2 North America In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America In - Vitro ADME Services Market Size by Country (2018-2023)
7.4 North America In - Vitro ADME Services Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe In - Vitro ADME Services Market Size (2018-2029)
8.2 Europe In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe In - Vitro ADME Services Market Size by Country (2018-2023)
8.4 Europe In - Vitro ADME Services Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific In - Vitro ADME Services Market Size (2018-2029)
9.2 Asia-Pacific In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific In - Vitro ADME Services Market Size by Country (2018-2023)
9.4 Asia-Pacific In - Vitro ADME Services Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America In - Vitro ADME Services Market Size (2018-2029)
10.2 Latin America In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America In - Vitro ADME Services Market Size by Country (2018-2023)
10.4 Latin America In - Vitro ADME Services Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa In - Vitro ADME Services Market Size (2018-2029)
11.2 Middle East & Africa In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa In - Vitro ADME Services Market Size by Country (2018-2023)
11.4 Middle East & Africa In - Vitro ADME Services Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River In - Vitro ADME Services Introduction
11.1.4 Charles River Revenue in In - Vitro ADME Services Business (2017-2022)
11.1.5 Charles River Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Detail
11.2.2 Labcorp Business Overview
11.2.3 Labcorp In - Vitro ADME Services Introduction
11.2.4 Labcorp Revenue in In - Vitro ADME Services Business (2017-2022)
11.2.5 Labcorp Recent Development
11.3 Envigo
11.3.1 Envigo Company Detail
11.3.2 Envigo Business Overview
11.3.3 Envigo In - Vitro ADME Services Introduction
11.3.4 Envigo Revenue in In - Vitro ADME Services Business (2017-2022)
11.3.5 Envigo Recent Development
11.4 Curia
11.4.1 Curia Company Detail
11.4.2 Curia Business Overview
11.4.3 Curia In - Vitro ADME Services Introduction
11.4.4 Curia Revenue in In - Vitro ADME Services Business (2017-2022)
11.4.5 Curia Recent Development
11.5 Evotec
11.5.1 Evotec Company Detail
11.5.2 Evotec Business Overview
11.5.3 Evotec In - Vitro ADME Services Introduction
11.5.4 Evotec Revenue in In - Vitro ADME Services Business (2017-2022)
11.5.5 Evotec Recent Development
11.6 Bioduro-Sundia
11.6.1 Bioduro-Sundia Company Detail
11.6.2 Bioduro-Sundia Business Overview
11.6.3 Bioduro-Sundia In - Vitro ADME Services Introduction
11.6.4 Bioduro-Sundia Revenue in In - Vitro ADME Services Business (2017-2022)
11.6.5 Bioduro-Sundia Recent Development
11.7 Lonza
11.7.1 Lonza Company Detail
11.7.2 Lonza Business Overview
11.7.3 Lonza In - Vitro ADME Services Introduction
11.7.4 Lonza Revenue in In - Vitro ADME Services Business (2017-2022)
11.7.5 Lonza Recent Development
11.8 WuXi AppTec
11.8.1 WuXi AppTec Company Detail
11.8.2 WuXi AppTec Business Overview
11.8.3 WuXi AppTec In - Vitro ADME Services Introduction
11.8.4 WuXi AppTec Revenue in In - Vitro ADME Services Business (2017-2022)
11.8.5 WuXi AppTec Recent Development
11.9 IQVIA
11.9.1 IQVIA Company Detail
11.9.2 IQVIA Business Overview
11.9.3 IQVIA In - Vitro ADME Services Introduction
11.9.4 IQVIA Revenue in In - Vitro ADME Services Business (2017-2022)
11.9.5 IQVIA Recent Development
11.10 Tecan Group
11.10.1 Tecan Group Company Detail
11.10.2 Tecan Group Business Overview
11.10.3 Tecan Group In - Vitro ADME Services Introduction
11.10.4 Tecan Group Revenue in In - Vitro ADME Services Business (2017-2022)
11.10.5 Tecan Group Recent Development
11.11 Pharmaron
11.11.1 Pharmaron Company Detail
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron In - Vitro ADME Services Introduction
11.11.4 Pharmaron Revenue in In - Vitro ADME Services Business (2017-2022)
11.11.5 Pharmaron Recent Development
11.12 Shanghai Medicilon
11.12.1 Shanghai Medicilon Company Detail
11.12.2 Shanghai Medicilon Business Overview
11.12.3 Shanghai Medicilon In - Vitro ADME Services Introduction
11.12.4 Shanghai Medicilon Revenue in In - Vitro ADME Services Business (2017-2022)
11.12.5 Shanghai Medicilon Recent Development
11.13 ChemPartner
11.13.1 ChemPartner Company Detail
11.13.2 ChemPartner Business Overview
11.13.3 ChemPartner In - Vitro ADME Services Introduction
11.13.4 ChemPartner Revenue in In - Vitro ADME Services Business (2017-2022)
11.13.5 ChemPartner Recent Development
11.14 Joinn Laboratories
11.14.1 Joinn Laboratories Company Detail
11.14.2 Joinn Laboratories Business Overview
11.14.3 Joinn Laboratories In - Vitro ADME Services Introduction
11.14.4 Joinn Laboratories Revenue in In - Vitro ADME Services Business (2017-2022)
11.14.5 Joinn Laboratories Recent Development
11.15 RTI International
11.15.1 RTI International Company Detail
11.15.2 RTI International Business Overview
11.15.3 RTI International In - Vitro ADME Services Introduction
11.15.4 RTI International Revenue in In - Vitro ADME Services Business (2017-2022)
11.15.5 RTI International Recent Development
11.16 Eurofins Scientific
11.16.1 Eurofins Scientific Company Detail
11.16.2 Eurofins Scientific Business Overview
11.16.3 Eurofins Scientific In - Vitro ADME Services Introduction
11.16.4 Eurofins Scientific Revenue in In - Vitro ADME Services Business (2017-2022)
11.16.5 Eurofins Scientific Recent Development
11.17 Aragen Life Sciences
11.17.1 Aragen Life Sciences Company Detail
11.17.2 Aragen Life Sciences Business Overview
11.17.3 Aragen Life Sciences In - Vitro ADME Services Introduction
11.17.4 Aragen Life Sciences Revenue in In - Vitro ADME Services Business (2017-2022)
11.17.5 Aragen Life Sciences Recent Development
11.18 Sai Life Sciences
11.18.1 Sai Life Sciences Company Detail
11.18.2 Sai Life Sciences Business Overview
11.18.3 Sai Life Sciences In - Vitro ADME Services Introduction
11.18.4 Sai Life Sciences Revenue in In - Vitro ADME Services Business (2017-2022)
11.18.5 Sai Life Sciences Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by End User (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global In - Vitro ADME Services Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global In - Vitro ADME Services Revenue Market Share by Type (2018-2023)
Table 7. Global In - Vitro ADME Services Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global In - Vitro ADME Services Revenue Market Share by Type (2024-2029)
Table 9. Global In - Vitro ADME Services Market Size by End User (2018-2023) & (US$ Million)
Table 10. Global In - Vitro ADME Services Revenue Market Share by End User (2018-2023)
Table 11. Global In - Vitro ADME Services Forecasted Market Size by End User (2024-2029) & (US$ Million)
Table 12. Global In - Vitro ADME Services Revenue Market Share by End User (2024-2029)
Table 13. Global In - Vitro ADME Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global In - Vitro ADME Services Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global In - Vitro ADME Services Market Share by Region (2018-2023)
Table 16. Global In - Vitro ADME Services Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global In - Vitro ADME Services Market Share by Region (2024-2029)
Table 18. In - Vitro ADME Services Market Trends
Table 19. In - Vitro ADME Services Market Drivers
Table 20. In - Vitro ADME Services Market Challenges
Table 21. In - Vitro ADME Services Market Restraints
Table 22. Global Top In - Vitro ADME Services Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global In - Vitro ADME Services Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global In - Vitro ADME Services Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of In - Vitro ADME Services, Headquarters and Area Served
Table 26. Global In - Vitro ADME Services Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global In - Vitro ADME Services by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America In - Vitro ADME Services Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America In - Vitro ADME Services Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe In - Vitro ADME Services Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe In - Vitro ADME Services Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific In - Vitro ADME Services Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific In - Vitro ADME Services Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America In - Vitro ADME Services Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America In - Vitro ADME Services Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa In - Vitro ADME Services Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa In - Vitro ADME Services Market Size by Country (2024-2029) & (US$ Million)
Table 45. Charles River Company Detail
Table 46. Charles River Business Overview
Table 47. Charles River In - Vitro ADME Services Product
Table 48. Charles River Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 49. Charles River Recent Development
Table 50. Labcorp Company Detail
Table 51. Labcorp Business Overview
Table 52. Labcorp In - Vitro ADME Services Product
Table 53. Labcorp Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 54. Labcorp Recent Development
Table 55. Envigo Company Detail
Table 56. Envigo Business Overview
Table 57. Envigo In - Vitro ADME Services Product
Table 58. Envigo Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 59. Envigo Recent Development
Table 60. Curia Company Detail
Table 61. Curia Business Overview
Table 62. Curia In - Vitro ADME Services Product
Table 63. Curia Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 64. Curia Recent Development
Table 65. Evotec Company Detail
Table 66. Evotec Business Overview
Table 67. Evotec In - Vitro ADME Services Product
Table 68. Evotec Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 69. Evotec Recent Development
Table 70. Bioduro-Sundia Company Detail
Table 71. Bioduro-Sundia Business Overview
Table 72. Bioduro-Sundia In - Vitro ADME Services Product
Table 73. Bioduro-Sundia Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 74. Bioduro-Sundia Recent Development
Table 75. Lonza Company Detail
Table 76. Lonza Business Overview
Table 77. Lonza In - Vitro ADME Services Product
Table 78. Lonza Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 79. Lonza Recent Development
Table 80. WuXi AppTec Company Detail
Table 81. WuXi AppTec Business Overview
Table 82. WuXi AppTec In - Vitro ADME Services Product
Table 83. WuXi AppTec Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 84. WuXi AppTec Recent Development
Table 85. IQVIA Company Detail
Table 86. IQVIA Business Overview
Table 87. IQVIA In - Vitro ADME Services Product
Table 88. IQVIA Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 89. IQVIA Recent Development
Table 90. Tecan Group Company Detail
Table 91. Tecan Group Business Overview
Table 92. Tecan Group In - Vitro ADME Services Product
Table 93. Tecan Group Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 94. Tecan Group Recent Development
Table 95. Pharmaron Company Detail
Table 96. Pharmaron Business Overview
Table 97. Pharmaron In - Vitro ADME ServicesProduct
Table 98. Pharmaron Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 99. Pharmaron Recent Development
Table 100. Shanghai Medicilon Company Detail
Table 101. Shanghai Medicilon Business Overview
Table 102. Shanghai Medicilon In - Vitro ADME ServicesProduct
Table 103. Shanghai Medicilon Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 104. Shanghai Medicilon Recent Development
Table 105. ChemPartner Company Detail
Table 106. ChemPartner Business Overview
Table 107. ChemPartner In - Vitro ADME ServicesProduct
Table 108. ChemPartner Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 109. ChemPartner Recent Development
Table 110. Joinn Laboratories Company Detail
Table 111. Joinn Laboratories Business Overview
Table 112. Joinn Laboratories In - Vitro ADME ServicesProduct
Table 113. Joinn Laboratories Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 114. Joinn Laboratories Recent Development
Table 115. RTI International Company Detail
Table 116. RTI International Business Overview
Table 117. RTI International In - Vitro ADME ServicesProduct
Table 118. RTI International Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 119. RTI International Recent Development
Table 120. Eurofins Scientific Company Detail
Table 121. Eurofins Scientific Business Overview
Table 122. Eurofins Scientific In - Vitro ADME ServicesProduct
Table 123. Eurofins Scientific Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 124. Eurofins Scientific Recent Development
Table 125. Aragen Life Sciences Company Detail
Table 126. Aragen Life Sciences Business Overview
Table 127. Aragen Life Sciences In - Vitro ADME ServicesProduct
Table 128. Aragen Life Sciences Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 129. Aragen Life Sciences Recent Development
Table 130. Sai Life Sciences Company Detail
Table 131. Sai Life Sciences Business Overview
Table 132. Sai Life Sciences In - Vitro ADME ServicesProduct
Table 133. Sai Life Sciences Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 134. Sai Life Sciences Recent Development
Table 135. Charles River Company Information
Table 136. Charles River Business Overview
Table 137. Charles River In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 138. Charles River Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 139. Charles River Recent Development
Table 140. Labcorp Company Information
Table 141. Labcorp Business Overview
Table 142. Labcorp In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 143. Labcorp Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 144. Labcorp Recent Development
Table 145. Envigo Company Information
Table 146. Envigo Business Overview
Table 147. Envigo In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 148. Envigo Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 149. Envigo Recent Development
Table 150. Curia Company Information
Table 151. Curia Business Overview
Table 152. Curia In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 153. Curia Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 154. Curia Recent Development
Table 155. Evotec Company Information
Table 156. Evotec Business Overview
Table 157. Evotec In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 158. Evotec Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 159. Evotec Recent Development
Table 160. Bioduro-Sundia Company Information
Table 161. Bioduro-Sundia Business Overview
Table 162. Bioduro-Sundia In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 163. Bioduro-Sundia Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 164. Bioduro-Sundia Recent Development
Table 165. Lonza Company Information
Table 166. Lonza Business Overview
Table 167. Lonza In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 168. Lonza Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 169. Lonza Recent Development
Table 170. WuXi AppTec Company Information
Table 171. WuXi AppTec Business Overview
Table 172. WuXi AppTec In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 173. WuXi AppTec Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 174. WuXi AppTec Recent Development
Table 175. IQVIA Company Information
Table 176. IQVIA Business Overview
Table 177. IQVIA In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 178. IQVIA Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 179. IQVIA Recent Development
Table 180. Tecan Group Company Information
Table 181. Tecan Group Business Overview
Table 182. Tecan Group In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 183. Tecan Group Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 184. Tecan Group Recent Development
Table 185. Pharmaron Company Information
Table 186. Pharmaron Business Overview
Table 187. Pharmaron In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 188. Pharmaron Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 189. Pharmaron Recent Development
Table 190. Shanghai Medicilon Company Information
Table 191. Shanghai Medicilon Business Overview
Table 192. Shanghai Medicilon In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 193. Shanghai Medicilon Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 194. Shanghai Medicilon Recent Development
Table 195. ChemPartner Company Information
Table 196. ChemPartner Business Overview
Table 197. ChemPartner In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 198. ChemPartner Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 199. ChemPartner Recent Development
Table 200. Joinn Laboratories Company Information
Table 201. Joinn Laboratories Business Overview
Table 202. Joinn Laboratories In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 203. Joinn Laboratories Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 204. Joinn Laboratories Recent Development
Table 205. RTI International Company Information
Table 206. RTI International Business Overview
Table 207. RTI International In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 208. RTI International Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 209. RTI International Recent Development
Table 210. Eurofins Scientific Company Information
Table 211. Eurofins Scientific Business Overview
Table 212. Eurofins Scientific In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 213. Eurofins Scientific Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 214. Eurofins Scientific Recent Development
Table 215. Aragen Life Sciences Company Information
Table 216. Aragen Life Sciences Business Overview
Table 217. Aragen Life Sciences In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 218. Aragen Life Sciences Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 219. Aragen Life Sciences Recent Development
Table 220. Sai Life Sciences Company Information
Table 221. Sai Life Sciences Business Overview
Table 222. Sai Life Sciences In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 223. Sai Life Sciences Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by End User (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global In - Vitro ADME Services Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global In - Vitro ADME Services Revenue Market Share by Type (2018-2023)
Table 7. Global In - Vitro ADME Services Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global In - Vitro ADME Services Revenue Market Share by Type (2024-2029)
Table 9. Global In - Vitro ADME Services Market Size by End User (2018-2023) & (US$ Million)
Table 10. Global In - Vitro ADME Services Revenue Market Share by End User (2018-2023)
Table 11. Global In - Vitro ADME Services Forecasted Market Size by End User (2024-2029) & (US$ Million)
Table 12. Global In - Vitro ADME Services Revenue Market Share by End User (2024-2029)
Table 13. Global In - Vitro ADME Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global In - Vitro ADME Services Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global In - Vitro ADME Services Market Share by Region (2018-2023)
Table 16. Global In - Vitro ADME Services Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global In - Vitro ADME Services Market Share by Region (2024-2029)
Table 18. In - Vitro ADME Services Market Trends
Table 19. In - Vitro ADME Services Market Drivers
Table 20. In - Vitro ADME Services Market Challenges
Table 21. In - Vitro ADME Services Market Restraints
Table 22. Global Top In - Vitro ADME Services Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global In - Vitro ADME Services Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global In - Vitro ADME Services Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of In - Vitro ADME Services, Headquarters and Area Served
Table 26. Global In - Vitro ADME Services Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global In - Vitro ADME Services by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America In - Vitro ADME Services Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America In - Vitro ADME Services Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe In - Vitro ADME Services Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe In - Vitro ADME Services Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific In - Vitro ADME Services Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific In - Vitro ADME Services Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America In - Vitro ADME Services Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America In - Vitro ADME Services Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa In - Vitro ADME Services Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa In - Vitro ADME Services Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa In - Vitro ADME Services Market Size by Country (2024-2029) & (US$ Million)
Table 45. Charles River Company Detail
Table 46. Charles River Business Overview
Table 47. Charles River In - Vitro ADME Services Product
Table 48. Charles River Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 49. Charles River Recent Development
Table 50. Labcorp Company Detail
Table 51. Labcorp Business Overview
Table 52. Labcorp In - Vitro ADME Services Product
Table 53. Labcorp Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 54. Labcorp Recent Development
Table 55. Envigo Company Detail
Table 56. Envigo Business Overview
Table 57. Envigo In - Vitro ADME Services Product
Table 58. Envigo Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 59. Envigo Recent Development
Table 60. Curia Company Detail
Table 61. Curia Business Overview
Table 62. Curia In - Vitro ADME Services Product
Table 63. Curia Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 64. Curia Recent Development
Table 65. Evotec Company Detail
Table 66. Evotec Business Overview
Table 67. Evotec In - Vitro ADME Services Product
Table 68. Evotec Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 69. Evotec Recent Development
Table 70. Bioduro-Sundia Company Detail
Table 71. Bioduro-Sundia Business Overview
Table 72. Bioduro-Sundia In - Vitro ADME Services Product
Table 73. Bioduro-Sundia Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 74. Bioduro-Sundia Recent Development
Table 75. Lonza Company Detail
Table 76. Lonza Business Overview
Table 77. Lonza In - Vitro ADME Services Product
Table 78. Lonza Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 79. Lonza Recent Development
Table 80. WuXi AppTec Company Detail
Table 81. WuXi AppTec Business Overview
Table 82. WuXi AppTec In - Vitro ADME Services Product
Table 83. WuXi AppTec Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 84. WuXi AppTec Recent Development
Table 85. IQVIA Company Detail
Table 86. IQVIA Business Overview
Table 87. IQVIA In - Vitro ADME Services Product
Table 88. IQVIA Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 89. IQVIA Recent Development
Table 90. Tecan Group Company Detail
Table 91. Tecan Group Business Overview
Table 92. Tecan Group In - Vitro ADME Services Product
Table 93. Tecan Group Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 94. Tecan Group Recent Development
Table 95. Pharmaron Company Detail
Table 96. Pharmaron Business Overview
Table 97. Pharmaron In - Vitro ADME ServicesProduct
Table 98. Pharmaron Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 99. Pharmaron Recent Development
Table 100. Shanghai Medicilon Company Detail
Table 101. Shanghai Medicilon Business Overview
Table 102. Shanghai Medicilon In - Vitro ADME ServicesProduct
Table 103. Shanghai Medicilon Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 104. Shanghai Medicilon Recent Development
Table 105. ChemPartner Company Detail
Table 106. ChemPartner Business Overview
Table 107. ChemPartner In - Vitro ADME ServicesProduct
Table 108. ChemPartner Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 109. ChemPartner Recent Development
Table 110. Joinn Laboratories Company Detail
Table 111. Joinn Laboratories Business Overview
Table 112. Joinn Laboratories In - Vitro ADME ServicesProduct
Table 113. Joinn Laboratories Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 114. Joinn Laboratories Recent Development
Table 115. RTI International Company Detail
Table 116. RTI International Business Overview
Table 117. RTI International In - Vitro ADME ServicesProduct
Table 118. RTI International Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 119. RTI International Recent Development
Table 120. Eurofins Scientific Company Detail
Table 121. Eurofins Scientific Business Overview
Table 122. Eurofins Scientific In - Vitro ADME ServicesProduct
Table 123. Eurofins Scientific Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 124. Eurofins Scientific Recent Development
Table 125. Aragen Life Sciences Company Detail
Table 126. Aragen Life Sciences Business Overview
Table 127. Aragen Life Sciences In - Vitro ADME ServicesProduct
Table 128. Aragen Life Sciences Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 129. Aragen Life Sciences Recent Development
Table 130. Sai Life Sciences Company Detail
Table 131. Sai Life Sciences Business Overview
Table 132. Sai Life Sciences In - Vitro ADME ServicesProduct
Table 133. Sai Life Sciences Revenue in In - Vitro ADME Services Business (2017-2022) & (US$ Million)
Table 134. Sai Life Sciences Recent Development
Table 135. Charles River Company Information
Table 136. Charles River Business Overview
Table 137. Charles River In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 138. Charles River Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 139. Charles River Recent Development
Table 140. Labcorp Company Information
Table 141. Labcorp Business Overview
Table 142. Labcorp In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 143. Labcorp Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 144. Labcorp Recent Development
Table 145. Envigo Company Information
Table 146. Envigo Business Overview
Table 147. Envigo In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 148. Envigo Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 149. Envigo Recent Development
Table 150. Curia Company Information
Table 151. Curia Business Overview
Table 152. Curia In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 153. Curia Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 154. Curia Recent Development
Table 155. Evotec Company Information
Table 156. Evotec Business Overview
Table 157. Evotec In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 158. Evotec Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 159. Evotec Recent Development
Table 160. Bioduro-Sundia Company Information
Table 161. Bioduro-Sundia Business Overview
Table 162. Bioduro-Sundia In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 163. Bioduro-Sundia Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 164. Bioduro-Sundia Recent Development
Table 165. Lonza Company Information
Table 166. Lonza Business Overview
Table 167. Lonza In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 168. Lonza Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 169. Lonza Recent Development
Table 170. WuXi AppTec Company Information
Table 171. WuXi AppTec Business Overview
Table 172. WuXi AppTec In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 173. WuXi AppTec Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 174. WuXi AppTec Recent Development
Table 175. IQVIA Company Information
Table 176. IQVIA Business Overview
Table 177. IQVIA In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 178. IQVIA Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 179. IQVIA Recent Development
Table 180. Tecan Group Company Information
Table 181. Tecan Group Business Overview
Table 182. Tecan Group In - Vitro ADME Services Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 183. Tecan Group Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 184. Tecan Group Recent Development
Table 185. Pharmaron Company Information
Table 186. Pharmaron Business Overview
Table 187. Pharmaron In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 188. Pharmaron Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 189. Pharmaron Recent Development
Table 190. Shanghai Medicilon Company Information
Table 191. Shanghai Medicilon Business Overview
Table 192. Shanghai Medicilon In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 193. Shanghai Medicilon Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 194. Shanghai Medicilon Recent Development
Table 195. ChemPartner Company Information
Table 196. ChemPartner Business Overview
Table 197. ChemPartner In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 198. ChemPartner Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 199. ChemPartner Recent Development
Table 200. Joinn Laboratories Company Information
Table 201. Joinn Laboratories Business Overview
Table 202. Joinn Laboratories In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 203. Joinn Laboratories Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 204. Joinn Laboratories Recent Development
Table 205. RTI International Company Information
Table 206. RTI International Business Overview
Table 207. RTI International In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 208. RTI International Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 209. RTI International Recent Development
Table 210. Eurofins Scientific Company Information
Table 211. Eurofins Scientific Business Overview
Table 212. Eurofins Scientific In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 213. Eurofins Scientific Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 214. Eurofins Scientific Recent Development
Table 215. Aragen Life Sciences Company Information
Table 216. Aragen Life Sciences Business Overview
Table 217. Aragen Life Sciences In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 218. Aragen Life Sciences Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
Table 219. Aragen Life Sciences Recent Development
Table 220. Sai Life Sciences Company Information
Table 221. Sai Life Sciences Business Overview
Table 222. Sai Life Sciences In - Vitro ADME ServicesRevenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million)
Table 223. Sai Life Sciences Revenue in In - Vitro ADME Services Business (2018-2023) & (US$ Million) Portfolio
